AGÕæÈ˹ٷ½

Twist Bioscience (TWST) filed a Form 144 indicating that Paula Green intends to sell up to 1,255 common shares through Fidelity on or after 4 Aug 2025. At the filing’s reference price, the proposed sale equals an aggregate market value of $35,596.95, representing only 0.002% of the 59.9 million shares outstanding. The shares were acquired via restricted-stock vesting on 1 Aug 2025 and are being sold as compensation-related disposals.

Green has already sold 3,020 shares over the past three months across five transactions, generating $102,916.31 in gross proceeds. No other insiders or affiliates are listed in the notice. The filer certifies no undisclosed adverse information and affirms compliance with Rule 144 requirements.

The planned sale is immaterial to corporate float but may interest investors tracking insider sentiment, as it continues a modest pattern of personal share disposals.

Celularity Inc. filed an 8-K reporting a private placement executed on 14 Jul 2025 with one institutional investor. The company will sell 1,230,769 Class A shares plus matching two-year warrants at a combined price of $1.625 per unit, generating $2.0 million in gross proceeds. Warrants are immediately exercisable at $1.50 and, if fully exercised, could add �$1.85 million more.

Securities are being issued under a Section 4(a)(2)/Rule 506(b) exemption and therefore are unregistered. Net proceeds are earmarked for working capital and general corporate purposes. The Purchase Agreement and Warrant include customary reps, warranties and closing conditions; full forms are attached as Exhibits 10.1 & 10.2.

The equity issuance implies an estimated �3-4 % dilution to the current share base, with incremental dilution possible upon warrant exercise. While the raise bolsters short-term liquidity, the relatively small size highlights Celularity’s ongoing reliance on external financing to advance its placental-derived cell therapy programs.

Auddia Inc. is calling its 2025 Annual Meeting for September [***], 2025 to vote on five key items.

Proposal 1: Elect four directors—Jeffrey Thramann (now CEO), Nick Balletta, Emmanuel de Boucaud and Joshua Sroge—following the July 2025 retirement of the prior CEO and three director resignations.
Proposal 2: Ratify Haynie & Company as auditor for FY 2025.
Proposal 3: Approve an amendment to the existing equity line with White Lion Capital that (i) extends the term to 12/31/2027 and (ii) raises the total commitment from $10 million to $50 million. Shares will be priced at 85-90% of market VWAP and capped at 9.99% ownership per purchase notice, but overall issuance could exceed 20% of current outstanding shares, triggering Nasdaq Rule 5635(d) shareholder-approval requirements.
Proposal 4: Approve share issuance above the 19.99% Nasdaq cap related to the June 30, 2025 $750k Series C convertible preferred financing (10% annual dividend, $4.77 conversion price, 314,466 five-year warrants; anti-dilution resets down to $0.954 floor).
Proposal 5: Amend the 2020 Equity Incentive Plan to (a) add an unspecified number of new shares (bumping the reserve above 67,899) and (b) raise the individual annual grant limit from 29,412 shares to an undisclosed higher amount.

Only holders of record on July [***], 2025 may vote. The board recommends FOR all proposals. Investors should weigh enhanced capital flexibility and refreshed governance against substantial dilution risk from the ELOC, preferred stock and enlarged option pool.

Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) announced, via a Form 6-K filing, that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of US$1.00 for listed securities on the Capital Market.

The company originally received a deficiency notice on January 15 2025 after its American depositary shares (ADSs) closed below US$1.00 for 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(A), Jianzhi was granted a 180-day cure period ending July 14 2025. According to the new Compliance Notice dated July 14 2025, the ADSs traded at or above US$1.00 for 18 consecutive business days from June 16 to July 11 2025, satisfying the 10-day requirement and closing the matter.

The filing removes the immediate risk of delisting, preserves exchange liquidity benefits, and signals market confidence sufficient to lift the share price back above the threshold without a reverse split or other corporate action. No additional financial data, earnings information, or major corporate transactions were disclosed in this report.

On 8 July 2025, Gray Media, Inc. (NYSE: GTN / GTN.A) filed an 8-K announcing that it has priced $900 million of 9.625% senior secured second-lien notes due 2032. The notes are being sold privately under Rule 144A/Reg S and will not be registered with the SEC.

Management plans to deploy the proceeds, together with draws on its revolving credit facility, to:

• Redeem all outstanding 7.000% senior notes maturing 2027
• Repay a portion of the company’s Term Loan F due 2029
• Cover related fees and expenses

The transaction lengthens Gray Media’s next major debt maturity from 2027 to 2032, reducing near-term refinancing risk. However, the coupon on the new bonds is 260 bp higher than the debt being retired, which will raise annual cash interest costs unless offset by other balance-sheet actions. As second-lien obligations, the new notes sit behind first-lien facilities but are senior to unsecured claims.

No updated guidance, pro-forma leverage or closing timetable was disclosed; the filing states that neither the press release nor the 8-K constitutes a formal offer to sell or notice of redemption.

Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., is offering 1-Year Barrier Securities linked to the S&P 500 Index (SPX). Each $1,000 security participates 100% in any positive index performance, but returns are capped at a minimum of 11.75%*. If, on the 8/03/26 valuation date, SPX closes between 80% and 100% of its initial level, holders receive full principal ($1,000). Should SPX fall below the 80% final barrier, repayment is reduced 1-for-1 with index decline, exposing investors to substantial loss—potentially their entire investment. The notes pay no coupons, provide no dividend participation, and will not be exchange-listed. All payments are subject to the credit risk of both Citigroup Global Markets Holdings Inc. and its parent, Citigroup Inc. Key dates include a 7/31/25 pricing date and 8/06/26 maturity. The preliminary pricing supplement (File Nos. 333-270327 & 333-270327-01) contains complete terms and risk factors, including an initial estimated value below the issue price.